BRWA
BCAB icon

B. Riley Wealth Advisors’s BioAtla BCAB Stock Holding History

B. Riley Wealth Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-600
Closed -$11.9K – 1085
2025
Q2 		$11.9K Buy
+600
New +$12.2K ﹤0.01% 1029
2024
Q4 		$17.7K Buy
+600
New +$50.4K ﹤0.01% 1132

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

B. Riley Wealth Advisors's BCAB Position: Q3 2025 in Review

B. Riley Wealth Advisors sold out of BioAtla (BCAB) in Q3 2025, closing a stake of 600 shares — an estimated $11.9K sold.

B. Riley Wealth Advisors first reported a position in BCAB in Q4 2024 and held it in 2 quarters. The position peaked at $17.7K in Q4 2024. 43 funds tracked by Wall St. Rank hold BCAB as of Q3 2025.

  • B. Riley Wealth Advisors reported no remaining BioAtla position as of Q3 2025 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 600 BioAtla shares in Q3 2025, an estimated $11.9K.
  • B. Riley Wealth Advisors first reported a position in BioAtla in Q4 2024 and held it in 2 quarters.
  • B. Riley Wealth Advisors's BioAtla position peaked at $17.7K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held BioAtla as of Q3 2025.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.